The efficacy and safety of 5α-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit–risk assessment of finasteride and dutasteride

@article{Gupta2014TheEA,
  title={The efficacy and safety of 5α-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit–risk assessment of finasteride and dutasteride},
  author={A. Gupta and Andrew Charrette},
  journal={Journal of Dermatological Treatment},
  year={2014},
  volume={25},
  pages={156 - 161}
}
  • A. Gupta, Andrew Charrette
  • Published 2014
  • Medicine
  • Journal of Dermatological Treatment
  • Introduction: In the light of post-marketing reports of persistent sexual dysfunction with the use of finasteride, analysis of the extent of risk associated with 5α-reductase inhibitor treatment for androgenetic alopecia (AGA) is warranted. This study sought to evaluate the efficacy of 5α-reductase inhibitors using the outcomes hair count, global photographic assessment and patient self-assessment and evaluate the benefits of treatment versus the risk of global sexual dysfunction. Methods: A… CONTINUE READING
    58 Citations

    Topics from this paper.

    Effect of 5α-Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Review of Randomized Controlled Trials.
    • 47
    5&agr;-Reductase inhibitors in androgenetic alopecia
    • 25

    References

    SHOWING 1-10 OF 40 REFERENCES
    Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review.
    • 148
    The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride.
    • 194
    • Highly Influential
    Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss.
    • 101
    • Highly Influential
    Finasteride in the treatment of Japanese men with male pattern hair loss.
    • 42
    • Highly Influential
    Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia.
    • Medicine
    • European journal of dermatology : EJD
    • 2002
    • 72
    Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss.
    • 78
    • Highly Influential
    Oral finasteride improved the quality of life of androgenetic alopecia patients
    • 24
    The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia.
    • 155